- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01021267
Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
November 25, 2009 updated by: A. Vogel AG
Clinical Pilot Trial on the Influence of a Saw Palmetto Berry Preparation on Sexual Functions in Patients With Benign Prostatic Hyperplasia
Assessment in an open trial if a standardized saw palmetto preparation has a positive influence on sexual dysfunctions in patients with BPH and sexual dysfunctions.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andy Suter, M.Sc.
- Phone Number: 0041714546203
- Email: a.suter@bioforce.ch
Study Locations
-
-
-
Chur, Switzerland, 7000
- Dr. Eugen Riedi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patients with BPH and sexual dysfunctions (erectile dysfunction or decrease in libido)
- IPSS > 4
- BSFI, sexual drive questions < 5
Exclusion Criteria:
- Lack of libido which is due to a psychic disease or a depressive mood -Excessivly strong lack of libido in the judgement of the investigator within the last two months
- Patients with severe vascular disorders (microangiopathies)
- Patients with known neuropathies
- Severe diabetes mellitus
- Patients with hypertension who are for less than two months on a stable antihypertensive medication
- Known bad compliance of the patient
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Saw palmetto berry extract
Saw palmetto berry extract, organic saw palmetto, ethanolic extract 96%
|
1x daily 1 capsule containing 320mg lipophilic extract
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of the brief Sexual Function Inventory
Time Frame: day 0 and day 56
|
day 0 and day 56
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change in IPSS change in Urolife Quality of Life questionnaire
Time Frame: day 0 and day 56
|
day 0 and day 56
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eugen Riedi, MD, Independent
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Anticipated)
September 1, 2010
Study Completion (Anticipated)
September 1, 2010
Study Registration Dates
First Submitted
November 25, 2009
First Submitted That Met QC Criteria
November 25, 2009
First Posted (Estimate)
November 26, 2009
Study Record Updates
Last Update Posted (Estimate)
November 26, 2009
Last Update Submitted That Met QC Criteria
November 25, 2009
Last Verified
November 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 920136
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia
-
San Carlo di Nancy HospitalElesta S.R.L.CompletedBenign Prostatic Hyperplasia | Benign Prostatic Hypertrophy | Benign Prostatic Hypertrophy With Outflow Obstruction | Prostate HyperplasiaItaly
-
IRCCS Policlinico S. MatteoCompletedBenign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow ObstructionItaly
-
Eli Lilly and CompanyCompletedBenign Prostatic Hyperplasia | Erectile DysfunctionUnited States, France, Italy, Greece, Mexico, Portugal, Canada, Germany, Russian Federation
-
Kasr El Aini HospitalUnknownMales With Benign Prostatic Hyperplasia Symptoms
-
Hanmi Pharmaceutical Company LimitedCompletedBenign Prostatic Hyperplasia | Erectile DysfunctionKorea, Republic of
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruitingLower Urinary Tract Symptoms | Benign Prostate Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction
-
EMSRecruitingBenign Prostatic Hyperplasia | Erectile DysfunctionBrazil
-
IlDong Pharmaceutical Co LtdUnknownBenign Prostatic Hyperplasia | Erectile DysfunctionKorea, Republic of
-
TakedaWithdrawnBenign Prostatic Hyperplasia | Erectile DysfunctionMexico
-
Eli Lilly and CompanyCompletedErectile Dysfunction | Benign Prostate HyperplasiaChina
Clinical Trials on Saw palmetto berry extract
-
innoVactiv Inc.CompletedBenign Prostatic HyperplasiaCanada
-
National Institute of Diabetes and Digestive and...National Center for Complementary and Integrative Health (NCCIH)Completed
-
RDC Clinical Pty LtdRecruitingBenign Prostatic HyperplasiaAustralia
-
Hospital Authority, Hong KongUnknownProstatic Hyperplasia | Adrenergic Alpha-AntagonistsChina
-
University of Alabama at BirminghamUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedUrologicalUnited States, Canada
-
Michigan State UniversityCompleted
-
SeppicRecruiting
-
Shin Kong Wu Ho-Su Memorial HospitalUnknownIncrease the Eradication Rate of Helicobacter PyloriTaiwan
-
Natural Immune Systems IncUnknownStem Cell Mobilization | Hematopoietic Stem Cell Mobilization | Stem Cell HomingUnited States